This week, Guardant Health held its InvestorDay, with a multi-hour presentation of the company's latest plans.
Response seems favorable, with JP Morgan reiterating its favorable "overweight" rating. Some of the key resources are online:
- News coverage here.
- Web page at Guardant here.
- There's a link for the 163-page PowerPoint, as well as for the streaming webcast.
- Direct to PPT here.
- It looks like Seeking Alpha has a full transcript free with registration, here.
- Shares have traded $58-62, for a market cap of about $7.5B.
I highlight two slides, an agenda slide and a strategy-overview slide, below, click to enlarge.
 |
| click to enlarge |
 |
| enlarge |
